We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+49.2%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.41B
AUM Growth
–
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
85.7%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$1.21B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Crestline Management, which disclosed 1 position worth $1.41B. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Juno Therapeutics, Inc.: 27,084,525 shares worth $1.41B.
- Crestline Management's largest Q4 2014 buy was Juno Therapeutics, Inc.: 27,084,525 shares worth $1.41B.
- Crestline Management's ten largest holdings make up 100% of its $1.41B portfolio in Q4 2014.
- Crestline Management disclosed 1 position in Q4 2014, its first 13F filing on record.
Based on Crestline Management's 13F filing for Q4 2014, filed 14 Jul 2015.